An evaluation of the benefits and harms of antenatal corticosteroid treatment for women at risk of imminent preterm birth or prior to elective Caesarean-section: Study protocol for an individual participant data meta-analysis

Wellcome Open Research
Elizabeth WastnedgeCo_Opt collaboration

Abstract

Background: Antenatal corticosteroid treatment (ACT) has been widely accepted as a safe, beneficial treatment which improves outcomes following preterm birth. It has been shown to reduce respiratory distress syndrome and neonatal mortality and is commonly used in threatened or planned preterm delivery, as well as prior to elective Caesarean-section at term. There are some concerns however, that in some cases, ACT is used in patients where clinical benefit has not been established, or may potentially increase harm. Many women who receive ACT do not deliver preterm and the long-term consequences of ACT treatment are unclear. This study aims to evaluate the benefits and harms of ACT using latest trial evidence to allow refinement of current practice. Methods: This study will compare ACT with placebo or non-treatment. Inclusion criteria are: Randomised Controlled Trials (RCT) comparing ACT vs. no ACT (with or without placebo) in all settings. Exclusion criteria are: non-randomised or quasi-randomised studies and studies comparing single vs. multiple courses of ACT. Main outcomes are to evaluate, for women at risk of preterm birth or undergoing planned Caesarean- section, the benefits and harms of ACT, on maternal, fetal, newborn, a...Continue Reading

References

Jun 21, 2001·Pediatric Pulmonology·R J BoltH A Delemarre-van de Waal
Mar 1, 2002·Evaluation & the Health Professions·Lesley A Stewart, Jayne F Tierney
Apr 27, 2005·BMC Medical Research Methodology·Gary H Lyman, Nicole M Kuderer
Aug 24, 2005·BMJ : British Medical Journal·Peter StutchfieldUNKNOWN Antenatal Steroids for Term Elective Caesarean Section (ASTECS) Research Team
Jul 19, 2006·American Journal of Obstetrics and Gynecology·Toril KolåsPål Øian
Oct 10, 2006·Pediatric Clinics of North America·Jeffrey A Whitsett, Yohei Matsuzaki
Sep 21, 2007·The New England Journal of Medicine·Caroline A CrowtherUNKNOWN ACTORDS Study Group
Sep 21, 2007·The New England Journal of Medicine·Ronald J WapnerUNKNOWN National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network
Oct 13, 2009·The Cochrane Database of Systematic Reviews·Alexandros SotiriadisJohn Pa Ioannidis
Feb 9, 2010·BMJ : British Medical Journal·Richard D RileyGhada Abo-Zaid
Apr 29, 2015·JAMA : the Journal of the American Medical Association·Lesley A StewartUNKNOWN PRISMA-IPD Development Group
Jul 6, 2015·The Cochrane Database of Systematic Reviews·Caroline A CrowtherJane E Harding
Nov 22, 2015·Human Reproduction Update·M W KempS J Stock
Dec 10, 2015·Obstetrics and Gynecology·Janneke van 't HooftUNKNOWN Global Obstetrics Network (GONet)
Feb 5, 2016·The New England Journal of Medicine·Cynthia Gyamfi-BannermanUNKNOWN NICHD Maternal–Fetal Medicine Units Network
Nov 15, 2016·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Ilhan Bahri DelibasOmer Erkan Yapca
Mar 23, 2017·The Cochrane Database of Systematic Reviews·Devender RobertsStuart R Dalziel
Jul 12, 2017·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Luke E GrzeskowiakBen W Mol
Jan 25, 2018·Journal of Tropical Pediatrics·Vijaya OntelaPalanivel Chinnakali
Apr 10, 2018·American Journal of Obstetrics and Gynecology·Alan H Jobe, Robert L Goldenberg
Jan 8, 2019·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Masoumeh MirzamoradiMahmood Bakhtiyari
Feb 3, 2019·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·UNKNOWN FIGO Working Group on Good Clinical Practice in Maternal-Fetal Medicine
Mar 28, 2019·Current Pharmaceutical Design·Lenka HrabalkovaSarah J Stock

❮ Previous
Next ❯

Software Mentioned

Co
PRISMA
opt

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.